Program availability

PSI offers assistance in a variety of diagnosis areas for prescribed products. Below is a list of our programs and their status.  Program availability can change throughout the day.  Status updates are made between the hours of 8:30am - 5:00pm EST, Monday-Friday.



The majority of our programs assist a mix of public and commercial insured patients.  These programs receive financial support from a variety of donors.



Idiopathic Pulmonary Fibrosis Program Now Accepting Applications.

bleeding disorders

Hemophilia (Bleeding Disorders)

  • Premium: This program is temporarily at 100% capacity. Our website will be updated as the program status changes.

Inhibitors in Bleeding

  • Premium: This program is accepting new applications.

South Carolina State Bleeding Disorders Program

  • Premium: Please call us at 1-800-366-7741 for more information or to apply for assistance.

von Willebrand disease (Bleeding Disorders)

  • Premium: This program is temporarily at 100% capacity. Our website will be updated as the program status changes.
cancer

Breakthrough Cancer Pain and Opioid Tolerant Therapies

  • Copayment: This program is accepting new applications.

Breast Cancer Screening

  • Ancillary Services: This program is accepting new applications.

Gastrointestinal Stromal Tumors

  • Copayment: This program is accepting new applications.

Malignant Ascites

  • Copayment: This program is accepting new applications.

Metastatic Melanoma

  • Travel Expenses: This program is accepting new applications.

Metastatic Renal Cell Carcinoma

  • Travel Expenses: This program is accepting new applications.
CARDIOVASCULAR DISEASE

Cardiovascular Copay Program

  • Copayment: This program is accepting new applications.
DIGESTIVE AND URINARY CONDITIONS

Kidney Stones

  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.
endocrine conditions

Fabry Disease

  • Ancillary Services: This program is accepting new applications.
  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.
  • Travel Expenses: This program is accepting new applications.

Gaucher Disease

  • Ancillary Services: This program is accepting new applications.
  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.
  • Travel Expenses: This program is accepting new applications.

Hypoparathyroidism

  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.
  • Travel Expenses: This program is accepting new applications.

Lysosomal Acid Lipase Deficiency (LAL D)

  • Ancillary Services: This program is accepting new applications.
  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.
  • Travel Expenses: This program is accepting new applications.

Mucopolysaccharidosis (MPS1)

  • Ancillary Services: This program is accepting new applications.
  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.
  • Travel Expenses: This program is accepting new applications.

Pompe Disease

  • Ancillary Services: This program is accepting new applications.
  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.
  • Travel Expenses: This program is accepting new applications.
immunodeficiency conditions

Complement Mediated Diseases (CMD)

  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.
  • Travel Expenses: This program is accepting new applications.

Hereditary Angioedema

  • Copayment: This program is temporarily at 100% capacity. Our website will be updated as the program status changes.
  • Premium: This program is temporarily at 100% capacity. Our website will be updated as the program status changes.
  • Travel Expenses: This program is temporarily at 100% capacity. Our website will be updated as the program status changes.
Primary Immune Deficiency
  • Premium:This program is temporarily at 100% capacity. Our website will be updated as the program status changes.
  • Hizentra Copayment: For drug copayment assistance, please contact 877-355-IGIQ (4447).
  • Hizentra Ancillary Services: This program is accepting new applications.
  • Hizentra Premium: This program is temporarily at 100% capacity. Our website will be updated as the program status changes.
Infectious conditions

Toxoplasmosis

  • Copayment: This program is accepting new applications.
leukemia and lymphoma

Chronic Myelogenous Leukemia (CML)

  • Copayment: This program is temporarily at 100% capacity. Our website will be updated as the program status changes.
nervous system conditions

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Premium: This program is accepting new applications.

Circadian Rhythm Disorders

  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.

Pseudobulbar Affect

  • Copayment: This program is accepting new applications.
respiratory conditions

Alpha-1 Antitrypsin Deficiency

  • Copayment: This program is temporarily at 100% capacity. Our website will be updated as the program status changes. 
  • Premium: This program is temporarily at 100% capacity. Our website will be updated as the program status changes.

Baxalta Alpha-1 Antitrypsin Deficiency Copay/Co-insurance Assistance Program*

  • Copayment: For drug copayment assistance, please contact 1-800-618-7527.

Cystic Fibrosis

  • Copayment: This program is accepting new applications.

Idiopathic Pulmonary Fibrosis

  • Copayment: This program is accepting new applications.
  • Premium: This program is accepting new applications.
  • Travel Expenses: This program is accepting new applications.

Pleural Effusion

  • Copayment: This program is accepting new applications.

Zemaira Financial Assistance Program*

  • Copayment: This program is accepting new applications for private insured patients only.
  • Premium: This program is accepting new applications for private insured patients only.


 

*Program supports commercial insured patients only.  Program is administered by PSI on behalf of the manufacturer.